Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence
Launched by FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR · Jan 14, 2025
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two treatments, neuromodulation and therapeutic exercise, on women who experience urge urinary incontinence (UUI), a common problem linked to overactive bladder. UUI can make it difficult for women to control their bladder, leading to unexpected leaks and frequent trips to the bathroom. The goal of this trial is to see if combining these two methods can help improve symptoms for those suffering from this condition.
To participate in the trial, women must be at least 45 years old, have been dealing with urinary incontinence for at least three months, and speak either Spanish or English. Certain health conditions or previous surgeries can exclude someone from joining. If eligible, participants can expect to receive treatment and support throughout the study, helping to improve their quality of life. This trial is currently recruiting participants, so it's a great opportunity for eligible women to explore new treatment options for their condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Present with a diagnosis of urinary incontinence or overactive bladder
- • Women of menopausal age (\>45 years)
- • ≥3 months of duration
- • Fulfill the established criteria for patient selection for neuromodulation treatment (urge urinary incontinence)
- • Speak native Spanish or English
- Exclusion Criteria:
- • Prior or scheduled surgical procedures in the lumbar or abdominal region
- • Presence of fractures or severe pathological conditions
- • Current pregnancy or potential for pregnancy during the study period
- • Neurological or psychiatric disorders
- • Presence of stress urinary incontinence
- • Female subjects with autoimmune diseases or malignancies
- • Belonephobia
- • Subjects who have undergone previous neuromodulation
About Fundación Universidad Católica De Valencia San Vicente Mártir
Fundación Universidad Católica de Valencia San Vicente Mártir is a prominent academic institution dedicated to advancing healthcare through innovative research and education. As a clinical trial sponsor, it leverages its robust medical and scientific expertise to conduct high-quality clinical studies aimed at improving patient outcomes and contributing to the advancement of medical knowledge. The foundation is committed to ethical research practices and collaboration with healthcare professionals, ensuring that its trials adhere to the highest standards of regulatory compliance and scientific integrity. Through its initiatives, it strives to foster a culture of excellence in clinical research and enhance the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported